| abstract |
Substituted 1H-pyrazolo[3,4-b]pyridine-3-yl-acrylamide compounds of formula (I) and pharmaceutically acceptable salts thereof, as defined in the specification, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful in therapy in the treatment of diseases associated with a dysregulated protein kinase activity, like cancer. |